[
  {
    "ts": null,
    "headline": "First Pacific Advisors' Strategic Moves: Becton Dickinson & Co Takes Center Stage",
    "summary": "Exploring the Latest 13F Filing for Q3 2025",
    "url": "https://finnhub.io/api/news?id=e3dabadf1c20e754a20870ac8da2ebfdb068186ecd27831616e32a2d48ca5379",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763074886,
      "headline": "First Pacific Advisors' Strategic Moves: Becton Dickinson & Co Takes Center Stage",
      "id": 137476799,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Exploring the Latest 13F Filing for Q3 2025",
      "url": "https://finnhub.io/api/news?id=e3dabadf1c20e754a20870ac8da2ebfdb068186ecd27831616e32a2d48ca5379"
    }
  },
  {
    "ts": null,
    "headline": "BDX Unveils Portable PureWick System for On-the-Go Incontinence Care",
    "summary": "BD expands its PureWick line with a portable system built for discreet, mobile incontinence care, aiming to deepen its home-care reach.",
    "url": "https://finnhub.io/api/news?id=59f0beb1c0f10f1ebbd896991a070b0487928cb1a9e36f1dcb5a48c94011f63c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763060400,
      "headline": "BDX Unveils Portable PureWick System for On-the-Go Incontinence Care",
      "id": 137473265,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD expands its PureWick line with a portable system built for discreet, mobile incontinence care, aiming to deepen its home-care reach.",
      "url": "https://finnhub.io/api/news?id=59f0beb1c0f10f1ebbd896991a070b0487928cb1a9e36f1dcb5a48c94011f63c"
    }
  },
  {
    "ts": null,
    "headline": "What Are Wall Street Analysts' Target Price for Becton, Dickinson and Company Stock?",
    "summary": "Although Becton, Dickinson and Company has underperformed the broader market over the past year, Wall Street analysts maintain a measured optimism about the company’s long-term outlook.",
    "url": "https://finnhub.io/api/news?id=add20d2912e7a7b1ec6bc4f20cac089820543d35c660046d2a2f781c861cb2cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763034956,
      "headline": "What Are Wall Street Analysts' Target Price for Becton, Dickinson and Company Stock?",
      "id": 137469322,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Although Becton, Dickinson and Company has underperformed the broader market over the past year, Wall Street analysts maintain a measured optimism about the company’s long-term outlook.",
      "url": "https://finnhub.io/api/news?id=add20d2912e7a7b1ec6bc4f20cac089820543d35c660046d2a2f781c861cb2cb"
    }
  },
  {
    "ts": null,
    "headline": "Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Duncan Regional Hospital (\"DRH Health\") has become the first hospital in the United States to implement BD Alaris™ EMR (Electronic Medical Record) Interoperability with the MEDITECH electronic health record (EHR), marking a significant advancement in patient safety, workflow efficiency and clinician support.",
    "url": "https://finnhub.io/api/news?id=a54517d766b8199290868fddbd939361636d1090b36bb3ff70fbd1779073332c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763034600,
      "headline": "Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH",
      "id": 137467253,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Duncan Regional Hospital (\"DRH Health\") has become the first hospital in the United States to implement BD Alaris™ EMR (Electronic Medical Record) Interoperability with the MEDITECH electronic health record (EHR), marking a significant advancement in patient safety, workflow efficiency and clinician support.",
      "url": "https://finnhub.io/api/news?id=a54517d766b8199290868fddbd939361636d1090b36bb3ff70fbd1779073332c"
    }
  },
  {
    "ts": null,
    "headline": "Some Investors May Be Willing To Look Past Becton Dickinson's (NYSE:BDX) Soft Earnings",
    "summary": "Soft earnings didn't appear to concern Becton, Dickinson and Company's ( NYSE:BDX ) shareholders over the last week. We...",
    "url": "https://finnhub.io/api/news?id=cd3ddfa59ab6fd1cbbcad246f905cdb6754a741ff77cf8d93bed1944f0892c42",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763033407,
      "headline": "Some Investors May Be Willing To Look Past Becton Dickinson's (NYSE:BDX) Soft Earnings",
      "id": 137467254,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Soft earnings didn't appear to concern Becton, Dickinson and Company's ( NYSE:BDX ) shareholders over the last week. We...",
      "url": "https://finnhub.io/api/news?id=cd3ddfa59ab6fd1cbbcad246f905cdb6754a741ff77cf8d93bed1944f0892c42"
    }
  },
  {
    "ts": null,
    "headline": "BD’s Q3 Earnings Call: Our Top 5 Analyst Questions",
    "summary": "BD’s third quarter results were broadly in line with Wall Street expectations, reflecting resilience across most of its product portfolio even as certain market headwinds emerged. Management credited strong demand in Interventional, Biologics, and Advanced Patient Monitoring segments for supporting organic growth, while acknowledging that vaccine demand and subdued research funding weighed on parts of the business. CEO Thomas Polen highlighted the sequential acceleration in organic growth and po",
    "url": "https://finnhub.io/api/news?id=c0a0ee7bd675e26218ee85dffd75dc11d1cca7c5d8c2fd555f8d1d57de3ace2c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763012369,
      "headline": "BD’s Q3 Earnings Call: Our Top 5 Analyst Questions",
      "id": 137468446,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD’s third quarter results were broadly in line with Wall Street expectations, reflecting resilience across most of its product portfolio even as certain market headwinds emerged. Management credited strong demand in Interventional, Biologics, and Advanced Patient Monitoring segments for supporting organic growth, while acknowledging that vaccine demand and subdued research funding weighed on parts of the business. CEO Thomas Polen highlighted the sequential acceleration in organic growth and po",
      "url": "https://finnhub.io/api/news?id=c0a0ee7bd675e26218ee85dffd75dc11d1cca7c5d8c2fd555f8d1d57de3ace2c"
    }
  }
]